Scott Patterson, formerly vice president of proteomics at Celera, has left the company, and started last week as CSO of Pasadena-based startup Farmal Biomedicines. Patterson told ProteoMonitor that Farmal, which plans to launch formally in March, will develop protein therapeutics in areas such as oncology.
Scott Patterson, Terrence Ryan, Nasri Nahas, David Rees, Arthur Patchett, Lawrence Glass, Ralph Ito
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.